Filer Snapshot

GENETHERA INC SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001017110.

Entity Type

Company

Total Filings

357

Latest Filing

11 Mar 2025

Industry

Biological Products, (No Disgnostic Substances)

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Go to latest filings table Browse SEC filer directory
Source: SEC filing REVOKED

REVOKED filed on 11 Mar 2025 for CIK 0001017110.

View Source Filing
Industry
Biological Products, (No Disgnostic Substances) (Office Of Life Sciences)
Business address
3051 W 105 Th Avenue, Unit 350251, Westminster, CO, 80031
State of incorporation
NV
Fiscal year end
31 December
Former names
HAND BRAND DISTRIBUTION INC (to 21 Nov 2003)

Key facts

  • GENETHERA INC is an SEC filer tracked under CIK 0001017110.
  • 357 filings are listed on this profile.
  • Common form coverage includes REVOKED, NT 10-K, UPLOAD and more.

Change

  • Latest filing: REVOKED filed on 11 Mar 2025.
  • Report period: not specified in filing header.

Research use

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Evidence

Source: SEC filing REVOKED

REVOKED filed on 11 Mar 2025 for CIK 0001017110.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed REVOKED can change the filing history, ownership context, or next research path for GENETHERA INC.

Latest source-backed update
REVOKED filed 11 Mar 2025
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: REVOKED filed 11 Mar 2025.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for GENETHERA INC

New fact period available

Latest financial period: Q4 2021. Open the source-backed page to inspect the fresh filing or facts context.

Update date

01 Feb 2023

Page type

Company facts

Latest period

Q4 2021

SEC-backed company facts were refreshed from filings filed on 01 Feb 2023.

Open company facts Browse recent public updates

Benchmark Context

Benchmark context for this company

GENETHERA INC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q4 2021. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 01 Feb 2023.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Company intelligence

GENETHERA INC: filings, ownership, insiders

CIK 0001017110. Open the active data lane, then verify the SEC filing behind the row.

Create free account to watch this company Open ownership signals

Active modules

2/5

Available company intelligence paths on this page.

Filings

357

SEC submissions provide the evidence trail.

Ownership context

0/3

Insider, large-stake, and institutional ownership lanes.

Return loop

Watch

Return when a new SEC-backed change lands.

Research checks

Latest filing

REVOKED filed 11 Mar 2025

Ownership lanes

0/3 active

CIK

0001017110

Next review

watch new filing, insider, 13D/G, or 13F change

SEC-verifiable company research path

Keep the next click tied to one changing object: a CIK, filing, insider, Schedule 13D/G holder, Form 13F manager, or security.

Open latest insider signals Open large-stake radar

SEC filings

Available

Latest company filings

Start with the filing timeline to verify the newest source document and report period.

Open filings table

Company facts

Available

Financial context

Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.

Open company facts

Forms 3/4/5

Explore

Insider activity

Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.

Browse latest insider filings

Schedule 13D/G

Explore

Large-stake holders

Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.

Browse large-stake radar

Form 13F

Explore

Institutional holders

Compare manager filings and smart-money context when company-level ownership needs broader holders.

Browse smart-money dashboard

SEC-verifiable company hub

Filings first, then ownership signals, insider context, and fundamentals.

Create free account to watch this company

Watchlist return triggers

Watch GENETHERA INC when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.

new company filing insider Form 4 13D/G holder change 13F holder update

Filer Overview

GENETHERA INC has filed 357 SEC EDGAR filings since 03 Sep 1999. Common forms include REVOKED, NT 10-K, UPLOAD, 10-K/A and more.

GENETHERA INC SEC filings GENETHERA INC company facts

Latest Filings

Recent SEC filings for GENETHERA INC with direct links to document and filing folders.

REVOKED File 000-27237

REVOKED filing

Filing date
11 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-27237

FORM NT 10-K

Filing date
31 Mar 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
02 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-27237

FORM 10-K/A

Filing date
01 Feb 2023
Reporting date
31 Dec 2021
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
27 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

NT 10-Q

Filing date
12 Aug 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

NT 10-Q

Filing date
13 May 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-27237

NT 10-K

Filing date
31 Mar 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. 10-Q

Filing date
16 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
D File 021-399719

D filing

Filing date
18 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

GENETHERA, INC. 8-K

Filing date
18 May 2021
Reporting date
23 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. 10-Q

Filing date
12 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
8-K File 000-27237

GENETHERA, INC. 8-K

Filing date
27 Apr 2021
Reporting date
09 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-27237

GENETHERA, INC. 10-K

Filing date
14 Apr 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
NT 10-K File 000-27237

GENETHERA, INC. NT 10-K

Filing date
31 Mar 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-27237

GENETHERA, INC. 10-Q/A

Filing date
18 Nov 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. 10-Q

Filing date
16 Nov 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
25 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-27237

GENETHERA, INC. 10-K/A, AMENDMENT NO. 1

Filing date
21 Sep 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
18 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-27237

GENETHERA, INC. 10-Q/A, AMENDMENT NO. 2

Filing date
10 Sep 2020
Reporting date
31 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. 10-Q

Filing date
14 Aug 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
10-Q/A File 000-27237

GENETHERA, INC. 03/31/2020 10-Q/A, AMENDMENT NO. 1

Filing date
13 Aug 2020
Reporting date
31 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. 10-Q

Filing date
24 Jun 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
10-K File 000-27237

GENETHERA, INC. 10-K

Filing date
10 Jun 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
8-K File 000-27237

GENETHERA, INC. 8-K

Filing date
15 May 2020
Reporting date
14 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

GENETHERA, INC. 8-K

Filing date
15 May 2020
Reporting date
14 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. 09/30/2019 10-Q

Filing date
31 Mar 2020
Reporting date
30 Sep 2019
Next action
Verify source filing
NT 10-K File 000-27237

GENETHERA, INC. NT 10-K

Filing date
30 Mar 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. 06/30/2019 10-Q

Filing date
30 Mar 2020
Reporting date
30 Jun 2019
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC.03/31/2019 10-Q

Filing date
26 Mar 2020
Reporting date
31 Mar 2019
Next action
Verify source filing
8-K File 000-27237

GENETHERA, INC. 8-K

Filing date
09 Mar 2020
Reporting date
09 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-27237

GENETHERA, INC. 10-K

Filing date
27 Feb 2020
Reporting date
31 Dec 2018
Next action
Verify source filing
NT 10-K File 000-27237

GENETHERA NT 10-K

Filing date
29 Mar 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

GENETHERA, INC. 8-K

Filing date
13 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

GENETHERA, INC. 8-K

Filing date
04 Dec 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-27237

GENETHERA, INC. JUNE 30, 2018 10-Q/A, AMENDMENT NO. 1

Filing date
03 Dec 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
10-Q/A File 000-27237

GENETHERA, INC. MARCH 31, 2018 10-Q/A, AMENDMENT NO. 1

Filing date
03 Dec 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. SEPTEMBER 30, 2018 10-Q

Filing date
30 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. JUNE 30, 2018 10-Q

Filing date
30 Nov 2018
Reporting date
30 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. MARCH 31, 2018 10-Q

Filing date
30 Nov 2018
Reporting date
31 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

FORM 8K CHANGE OF AUDITORS

Filing date
12 Sep 2018
Reporting date
12 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

8K

Filing date
31 Aug 2018
Reporting date
31 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

FORM 12B-25

Filing date
14 Nov 2016
Reporting date
30 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-27237

FROM 10Q/A AMENDMENT NO1

Filing date
23 Aug 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
NT 10-Q File 000-27237

FORM 12B-25

Filing date
12 Aug 2016
Reporting date
30 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

FORM 12B-25

Filing date
16 May 2016
Reporting date
31 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-27237

FORM 12B-25

Filing date
30 Mar 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

NOTICE OF LATE FILING

Filing date
16 Nov 2015
Reporting date
30 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

NT 10-Q filing

Filing date
12 Aug 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

10-Q filing

Filing date
20 May 2015
Reporting date
31 Mar 2015
Next action
Verify source filing
NT 10-Q File 000-27237

NT 10-Q filing

Filing date
14 May 2015
Reporting date
31 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

8-K filing

Filing date
21 Apr 2015
Reporting date
21 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-27237

10-K filing

Filing date
14 Apr 2015
Reporting date
31 Dec 2014
Next action
Verify source filing
NT 10-K File 000-27237

NT 10-K filing

Filing date
27 Mar 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

8K

Filing date
04 Mar 2015
Reporting date
04 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

8-K filing

Filing date
03 Feb 2015
Reporting date
22 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

QUARTERLY FILING

Filing date
19 Nov 2014
Reporting date
30 Sep 2014
Next action
Verify source filing
NT 10-Q/A File 000-27237

NT 10-Q/A filing

Filing date
13 Nov 2014
Reporting date
30 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

NT 10-Q filing

Filing date
13 Nov 2014
Reporting date
30 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

QUARTERLY REPORT

Filing date
19 Aug 2014
Reporting date
30 Jun 2014
Next action
Verify source filing
NT 10-Q File 000-27237

LATE FILING NOTIFICATION

Filing date
13 Aug 2014
Reporting date
30 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

10-Q filing

Filing date
13 May 2014
Reporting date
31 Mar 2014
Next action
Verify source filing
NT 10-K File 000-27237

UNITED STATES

Filing date
31 Mar 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

UNITED STATES

Filing date
14 Nov 2013
Reporting date
30 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-27237

AMENDMENT TO QUARTERLY REPORT

Filing date
05 Sep 2013
Reporting date
30 Jun 2013
Next action
Verify source filing
NT 10-Q File 000-27237

UNITED STATES

Filing date
14 Aug 2013
Reporting date
30 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

UNITED STATES

Filing date
15 May 2013
Reporting date
15 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-27237

GENETHERA, INC. FORM 12B-25 FOR DECEMBER 31, 2012

Filing date
29 Mar 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

FORM NT 10Q

Filing date
14 Nov 2012
Reporting date
30 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

ITEM 8.01

Filing date
28 Sep 2012
Reporting date
28 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-27237

GENETHERA INC FORM 10-QA JUNE 30, 2012

Filing date
07 Sep 2012
Reporting date
30 Jun 2012
Next action
Verify source filing
10-Q File 000-27237

10Q

Filing date
20 Aug 2012
Reporting date
30 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

LATE NOTIFICATION FILING

Filing date
14 Aug 2012
Reporting date
30 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

8K

Filing date
18 May 2012
Reporting date
17 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

CONVERTED BY EDGARWIZ

Filing date
17 May 2012
Reporting date
31 Mar 2012
Next action
Verify source filing
NT 10-Q File 000-27237

UNITED STATES

Filing date
15 May 2012
Reporting date
31 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-27237

FORM 10-Q/A

Filing date
11 Apr 2012
Reporting date
30 Sep 2011
Next action
Verify source filing
8-K File 000-27237

NON-RELIANCE ON PREVIOUS FINANCIAL STATEMENT DATED 9-30-2011

Filing date
06 Apr 2012
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-27237

LATE FILING NOTIFICATION

Filing date
29 Mar 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

8K

Filing date
05 Mar 2012
Reporting date
05 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

8-K

Filing date
26 Jan 2012
Reporting date
25 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27237

ITEM 5

Filing date
18 Jan 2012
Reporting date
18 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
09 Jan 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
05 Jan 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jan 2012
Reporting date
21 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jan 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

GENETHERA, INC. 10Q 2011-06-30

Filing date
23 Nov 2011
Reporting date
30 Jun 2011
Next action
Verify source filing
10-Q File 000-27237

CONVERTED BY EDGARWIZ

Filing date
21 Nov 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

CONVERTED BY EDGARWIZ

Filing date
21 Nov 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

CONVERTED BY EDGARWIZ

Filing date
21 Nov 2011
Reporting date
30 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

CONVERTED BY EDGARWIZ

Filing date
21 Nov 2011
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-27237

CONVERTED BY EDGARWIZ

Filing date
21 Nov 2011
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

CONVERTED BY EDGARWIZ

Filing date
18 Nov 2011
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-27237

UNITED STATES

Filing date
15 Nov 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-27237

CONVERTED BY EDGARWIZ

Filing date
14 Nov 2011
Reporting date
30 Sep 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-27237

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Filing date
04 Nov 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-27237

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Filing date
03 Nov 2011
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing

About this filer

GENETHERA INC files with the SEC under CIK 0001017110. This page aggregates EDGAR filings and related ownership activity.

Industry: Biological Products, (No Disgnostic Substances).

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .